Magnus Gisslén Selected Research

Biomarkers (Surrogate Marker)

11/2023	Reply to Dr Finsterer; CSF biomarkers of neuronal/glial damage or immune activation are unsuitable for assessing post-COVID cognitive impairment.
10/2023	COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
1/2023	Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.
1/2023	Cognitive impairment in people living with HIV: consensus recommendations for a new approach.
1/2023	Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms.
1/2023	Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
11/2022	Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses.
7/2022	Blood biomarkers for HIV infection with focus on neurologic complications-A review.
1/2022	Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
1/2022	Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Gisslén Research Topics

Disease

33	Infections 05/2024 - 11/2002
33	COVID-19 11/2023 - 01/2020
30	HIV Infections (HIV Infection) 04/2024 - 08/2005
9	Acquired Immunodeficiency Syndrome (AIDS) 03/2023 - 02/2007
9	Viremia 01/2023 - 07/2009
8	Dementia (Dementias) 05/2024 - 01/2014
7	Inflammation (Inflammations) 01/2023 - 12/2009
7	Central Nervous System Infections (Central Nervous System Infection) 01/2022 - 12/2010
6	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2009
5	Cognitive Dysfunction 11/2023 - 04/2016
4	Neurocognitive Disorders (Clerambault Syndrome) 01/2023 - 12/2011
4	Neuroinflammatory Diseases 01/2020 - 02/2013
4	Leukocytosis (Pleocytosis) 09/2012 - 07/2004
3	Persistent Infection 05/2024 - 01/2018
3	Brain Injuries (Brain Injury) 11/2022 - 12/2009
3	Neurologic Manifestations (Neurological Manifestations) 01/2022 - 09/2012
2	Neoplasms (Cancer) 01/2023 - 06/2021
2	Critical Illness (Critically Ill) 12/2022 - 01/2022
2	Opportunistic Infections (Opportunistic Infection) 07/2022 - 12/2009
2	Disease Progression 01/2022 - 06/2013
2	Hypertension (High Blood Pressure) 01/2021 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2007
2	AIDS Dementia Complex 12/2009 - 09/2006
1	Multiple Sclerosis 04/2024
1	Mental Disorders (Mental Disorder) 11/2023
1	Severe Acute Respiratory Syndrome 01/2023
1	Hemorrhage 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Human Influenza (Influenza) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2006
16	RNA (Ribonucleic Acid)IBA 05/2024 - 08/2005
15	Proteins (Proteins, Gene)FDA Link 05/2024 - 12/2009
9	Immunoglobulin G (IgG)IBA 04/2024 - 01/2020
9	NeopterinIBA 12/2021 - 07/2004
6	AntibodiesIBA 01/2023 - 01/2018
5	Amyloid (Amyloid Fibrils)IBA 01/2023 - 12/2009
5	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2023 - 01/2015
5	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2006
4	Ritonavir (Norvir)FDA Link 01/2016 - 09/2006
3	VaccinesIBA 11/2023 - 12/2022
3	Viral RNAIBA 10/2022 - 01/2021
3	enzalutamideIBA 06/2022 - 03/2021
3	Indicators and Reagents (Reagents)IBA 02/2020 - 08/2007
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2006
3	Serum AlbuminIBA 01/2017 - 06/2013
3	Amyloid beta-PeptidesIBA 06/2013 - 12/2009
2	AntigensIBA 10/2023 - 02/2016
2	Immunoglobulin M (IgM)IBA 01/2023 - 01/2023
2	ChAdOx1 nCoV-19IBA 01/2023 - 12/2022
2	Viral AntigensIBA 01/2023 - 01/2022
2	AutoantibodiesIBA 01/2023 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2020
2	Glial Fibrillary Acidic ProteinIBA 11/2022 - 01/2020
2	CytokinesIBA 11/2022 - 01/2019
2	Androgen Antagonists (Antiandrogens)IBA 06/2022 - 01/2022
2	Testosterone (Sustanon)FDA Link 01/2022 - 03/2021
2	HomocysteineIBA 01/2022 - 01/2016
2	AlbuminsIBA 12/2021 - 01/2014
2	Lamivudine (Epivir)FDA Link 01/2021 - 09/2006
2	RacivirIBA 11/2019 - 01/2017
2	Drug CombinationsIBA 01/2018 - 03/2006
2	HIV AntibodiesIBA 01/2018 - 02/2016
2	Lipopolysaccharide ReceptorsIBA 12/2017 - 04/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 01/2006
2	Protons (Proton)IBA 12/2015 - 06/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 06/2011 - 01/2005
1	ProteomeIBA 05/2024
1	Cerebrospinal Fluid ProteinsIBA 05/2024
1	Immunoglobulins (Immunoglobulin)IBA 04/2024
1	COVID-19 VaccinesIBA 11/2023
1	Arginine (L-Arginine)FDA Link 10/2023
1	Glutamic Acid (Glutamate)FDA Link 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2023
1	Sirtuin 2IBA 01/2023
1	SynucleinsIBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	InterferonsIBA 01/2023
1	Protein SIBA 01/2023
1	IntegrinsIBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	NAD (NADH)IBA 01/2023
1	AutoantigensIBA 01/2023
1	EpitopesIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	Small Cytoplasmic RNAIBA 12/2022
1	mRNA VaccinesIBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	Betamethasone (Celestone)FDA Link 10/2022
1	remdesivirIBA 10/2022

Therapy/Procedure

20	Therapeutics 03/2023 - 11/2002
9	Highly Active Antiretroviral Therapy (HAART) 06/2021 - 09/2006
8	Art Therapy 03/2023 - 01/2016
4	Critical Care (Surgical Intensive Care) 12/2022 - 05/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 03/2021
1	Hysterectomy 01/2023